Remitly (RELY) Form 144 Discloses Option Exercise and Proposed Sale

Rhea-AI Filing Summary

Remitly Global, Inc. (RELY) Form 144 notice reports a proposed sale of 5,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $99,850. The filing states these shares were acquired on 08/14/2025 by exercising stock options and paid for in cash the same day. The filer also disclosed two prior 10b5-1 sales by the same person in June 2025, each of 5,000 shares generating gross proceeds of $102,400 (06/17/2025) and $101,700 (06/10/2025). The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Positive

• Disclosure compliance: Form 144 includes acquisition method, broker details, quantity, market value, and recent sales as required
• Use of 10b5-1 plans: Prior June 2025 sales were executed under 10b5-1, indicating preplanned trading activity

Negative

• Insider liquidity: The filer has sold a total of 15,000 shares disclosed here and in June 2025, which increases share supply from insiders

Insights

Securities Analyst

TL;DR: Insider exercised options and plans a small sale of 5,000 shares; two prior 10b5-1 sales of 10,000 shares occurred in June.

The filing documents a routine Rule 144 notice for sale of 5,000 Remitly common shares acquired by option exercise on 08/14/2025 and to be sold via Morgan Stanley on NASDAQ for an indicated aggregate market value of $99,850. Recent disclosed 10b5-1 trading in June 2025 shows two separate 5,000-share sales, which are relevant for tracking insider liquidity and potential supply into the market. This submission is procedural and reflects insider monetization rather than operational developments.

Corporate Governance Expert

TL;DR: Filing appears compliant and includes the required representations; transactions are disclosed as exercised options and 10b5-1 sales.

The Form 144 contains the expected elements: issuer and broker details, quantity and market value, acquisition method (exercise of stock options), payment method (cash), and recent related sales under 10b5-1 plans. The signer affirms no undisclosed material adverse information and notes plan/adoption details are present where applicable. From a governance perspective, disclosure is consistent with Rule 144 obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	99850.00	206193217	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2025	Exercise of Stock Options	Issuer			5000	08/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PHILLIP RIESE 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	06/17/2025	5000	102400.00
10b5-1 Sales for PHILLIP RIESE 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	06/10/2025	5000	101700.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for RELY report?

It reports a proposed sale of 5,000 common shares acquired by option exercise on 08/14/2025 with aggregate market value of $99,850, to be sold via Morgan Stanley on NASDAQ.

How were the 5,000 shares acquired according to the filing?

The filing states the shares were acquired on 08/14/2025 through exercise of stock options and paid for in cash the same day.

Were there any recent related insider sales for RELY?

Yes. Two 10b5-1 sales by the same person in June 2025 each sold 5,000 shares for gross proceeds of $101,700 (06/10/2025) and $102,400 (06/17/2025).

Which broker will handle the proposed sale?

The proposed sale lists Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, New York, NY) as the broker.

On which exchange will the RELY shares be sold?

The filing specifies the NASDAQ exchange as the securities exchange for the sale.